Clinical Trials Register

Trials with a EudraCT protocol (158)
Paediatric studies in scope of Art45 of the Paediatric Regulation (0)

158 result(s) found for: Cardiac Arrhythmia. Displaying page 8 of 8.

EudraCT Number: 2016-004121-16

Sponsor Protocol Number: AC16141

Start Date*: 2017-09-11

Sponsor Name:University of Edinburgh

Full Title: Start or STop Anticoagulants Randomised Trial (SoSTART) after spontaneous intracranial haemorrhage

Medical condition: Spontaneous Intracranial Haemorrhage (ICH)

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	20.0	100000004852	10022753	Intracerebral haemorrhage	LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: GB (GB - no longer in EU/EEA)

Trial results: View results

EudraCT Number: 2008-007974-39

Sponsor Protocol Number: AIO-KRK-0207

Start Date*: 2009-08-04

Sponsor Name:AIO-Studien-gGmbH

Full Title: Randomized three arm phase III trial on induction treatment with a fluoropyrimidine-, oxaliplatin- and bevacizumab-based chemotherapy for 24 weeks followed by maintenance treatment with a fluoropyr...

Medical condition: Histologically confirmed and inoperable or irresectable metastatic colorectal cancer (stage IV)

Disease:	Version	SOC Term	Classification Code	Term	Level
	14.1	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10052362	Metastatic colorectal cancer	LLT
	14.1	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10010035	Colorectal cancer stage IV	PT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: DE (Completed)

Trial results: View results

EudraCT Number: 2012-003229-91

Sponsor Protocol Number: POL6326-POL-006

Start Date*: 2013-06-27

Sponsor Name:Polyphor AG

Full Title: CXCR4 Antagonism for Cell Mobilisation and Healing in Acute Myocardial Infarction (CATCH-AMI) A Phase IIa, Double-Blind, Placebo-Controlled, Randomised, Multi-centre Study of POL6326, a CXCR4 A...

Medical condition: Acute Myocardial Infarction

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	18.0	100000004849	10064345	ST segment elevation myocardial infarction	LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: DE (Completed) GB (Completed) AT (Completed) HU (Completed) PL (Completed) CZ (Completed) NO (Completed) HR (Completed)

Trial results: View results

EudraCT Number: 2011-006342-32

Sponsor Protocol Number: 75111-10114

Start Date*: 2013-06-11

Sponsor Name:EORTC

Full Title: Pertuzumab + trastuzumab (PH) versus PH plus metronomic chemotherapy (PHM) in the elderly HER2+ metastatic breast cancer population who may continue on T-DM1 alone following disease progression whi...

Medical condition: Newly diagnosed or recurrent (after surgery) stage IV (TNM/AJCC v.7) HER-2 positive (IHC 3+ or or HER-2 gene amplification by in situ hybridization) invasive breast cancer

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	20.0	100000004864	10027475	Metastatic breast cancer	LLT

Population Age: Adults, Elderly

Gender: Female

Trial protocol: BE (Completed) IT (Completed) PT (Completed) NL (Completed) GB (GB - no longer in EU/EEA) SE (Completed)

Trial results: View results

EudraCT Number: 2004-000715-26

Sponsor Protocol Number: BO17920

Start Date*: 2005-02-02

Sponsor Name:F. Hoffmann-La Roche Ltd.

Full Title: A Randomized, Three Arm Multinational Phase III Study to Investigate Bevacizumab (q3w or q2w) in Combination With Either Intermittent Capecitabine Plus Oxaliplatin (XELOX) (q3w) or Fluorouracil/ Le...

Medical condition: Adjuvant treatment for patients who have undergone surgery for Colon cancer, AJCC/UICC high-risk Stage II & stage III

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	7		10009954		PT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: FI (Completed) SE (Completed) DE (Completed) HU (Completed) GB (Completed) CZ (Completed) ES (Completed) IT (Completed)

Trial results: View results

EudraCT Number: 2018-000096-32

Sponsor Protocol Number: METRO-PD1-1708

Start Date*: 2018-11-15

Sponsor Name:Centre Oscar Lambret

Full Title: Metro-PD1: a phase I/II trial evaluating anti-PD1 (Nivolumab) in combination with metronomic chemotherapy in children and teenagers with refractory /relapsing solid tumors or lymphoma

Medical condition: Progressive or refractory : • high grade glioma • neuroblastoma • other cerebral tumors • lymphoma

Disease:	Version	SOC Term	Classification Code	Term	Level
	20.0	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10018338	Glioma	PT
	20.0	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10029260	Neuroblastoma	PT
	20.0	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10006153	Brain tumor	LLT
	20.0	10005329 - Blood and lymphatic system disorders	10025323	Lymphomas NEC	HLGT

Population Age: Children, Adolescents, Under 18, Adults

Gender: Male, Female

Trial protocol: FR (Trial now transitioned) BE (Prematurely Ended)

Trial results: (No results available)

EudraCT Number: 2011-000811-23

Sponsor Protocol Number:

Start Date*: 2012-06-22

Sponsor Name:University Hospital Southampton NHS Foundation Trust

Full Title: Treatment of neonatal chronic lung disease (nCLD). The Surfactant, Nutrition and Microorganism Interactions study in infants at risk of developing chronic lung disease - 2 (TSuNaMI-II)

Medical condition: neonatal chronic lung disease bronchopulmonary dysplasia

Disease:	Version	SOC Term	Classification Code	Term	Level
	14.1	10022117 - Injury, poisoning and procedural complications	10063349	Endotracheal intubation complication	PT
	14.1	10042613 - Surgical and medical procedures	10044107	Total parenteral nutrition	LLT
	14.1	10029205 - Nervous system disorders	10018985	Haemorrhage intracranial	PT
	14.1	10021881 - Infections and infestations	10069719	Bacterial colonisation	LLT
	14.1	10047065 - Vascular disorders	10021097	Hypotension	PT
	14.1	10007541 - Cardiac disorders	10006093	Bradycardia	PT
	14.1	10038738 - Respiratory, thoracic and mediastinal disorders	10002974	Apnoea	PT
	14.1	10038738 - Respiratory, thoracic and mediastinal disorders	10037395	Pulmonary haemorrhage of fetus or newborn	LLT
	14.1	10021881 - Infections and infestations	10040047	Sepsis	PT
	14.1	10038738 - Respiratory, thoracic and mediastinal disorders	10035759	Pneumothorax	PT
	14.1	10038738 - Respiratory, thoracic and mediastinal disorders	10006475	Bronchopulmonary dysplasia	PT
	14.1	10038738 - Respiratory, thoracic and mediastinal disorders	10058490	Hyperoxia	PT

Population Age: Preterm newborn infants, Under 18

Gender: Male, Female

Trial protocol: GB (GB - no longer in EU/EEA)

Trial results: (No results available)

EudraCT Number: 2018-001795-38

Sponsor Protocol Number: ALLTogether1

Start Date*: 2020-05-15

Sponsor Name:Karolinska University Hospital

Full Title: ALLTogether1– A Treatment study protocol of the ALLTogether Consortium for children and young adults (0-45 years of age) with newly diagnosed acute lymphoblastic leukaemia (ALL)

Medical condition: Acute lymphoblastic leukaemia (ALL)

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	21.0	100000004864	10000844	Acute lymphoblastic leukaemia	LLT

Population Age: Infants and toddlers, Children, Adolescents, Under 18, Adults

Gender: Male, Female

Trial protocol: DE (Trial now transitioned) FI (Trial now transitioned) SE (Trial now transitioned) DK (Trial now transitioned) IE (Trial now transitioned) GB (GB - no longer in EU/EEA) BE (Trial now transitioned) PT (Trial now transitioned) LT (Trial now transitioned) NO (Trial now transitioned) NL (Trial now transitioned) FR (Trial now transitioned) IS (Trial now transitioned)

Trial results: (No results available)

EudraCT Number: 2019-001857-13

Sponsor Protocol Number: NODE-303

Start Date*: 2020-04-09

Sponsor Name:Milestone Pharmaceuticals Inc.

Full Title: Multi-Centre, Multi-National, Open Label, Safety Study of Etripamil Nasal Spray for Patients with Paroxysmal Supraventricular Tachycardia

Medical condition: Treatment of Paroxysmal Supraventricular Tachycardia

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	20.0	100000004849	10034044	Paroxysmal supraventricular tachycardia	LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: FR (Completed) BE (Completed) NL (Completed) DE (Completed) HU (Completed) DK (Completed) CZ (Completed) SK (Completed) GB (GB - no longer in EU/EEA) ES (Prematurely Ended) PL (Completed) IT (Prematurely Ended)

Trial results: View results

EudraCT Number: 2010-023668-42

Sponsor Protocol Number: CRI 102194

Start Date*: 2011-02-03

Sponsor Name:Southampton University Hospital NHS Trust

Full Title: Pulmonary surfactant (S) biology in ventilated children on a paediatric intensive care unit with acute (A) hypoxic respiratory (R) failure- a pilot (P) study (S): (SARPS)

Medical condition: acute hypoxic respiratory failure in children ventilated on paediatric intensive care

Disease:	Version	SOC Term	Classification Code	Term	Level
	12.1		10040047	Sepsis	PT
	12.1		10018985	Haemorrhage intracranial	PT
	12.1		10006093	Bradycardia	PT
	12.1		10021097	Hypotension	PT
	12.1		10006475	Bronchopulmonary dysplasia	PT
	12.1		10035759	Pneumothorax	PT
	12.1		10037394	Pulmonary haemorrhage	PT
	12.1		10058490	Hyperoxia	PT
	12.1		10011705	Cyanosis neonatal	PT
	12.1		10002974	Apnoea	PT
	12.1		10033318	Oxygen saturation decreased	PT
	12.1		10014408	Electroencephalogram abnormal	PT
	12.1		10063349	Endotracheal intubation complication	PT

Population Age: Newborns, Infants and toddlers, Children, Adolescents, Under 18

Gender: Male, Female

Trial protocol: GB (GB - no longer in EU/EEA)

Trial results: (No results available)

EudraCT Number: 2006-004529-27	Sponsor Protocol Number: 1216.18	Start Date*: 2007-07-09
Sponsor Name:SCS Boehringer Ingelheim Comm.V
Full Title: Multicenter parallel phase II trial of BI 2536 administered as one hour i.v. infusion every 3 weeks in defined cohorts of patients with various solid tumours. A new drug screening program of the EO...
Medical condition: patients with five different tumour entities will be included in the present trial: 1. squamous cell carinoma of the head and neck 2. breast cancer 3. ovarian cancer 4. soft tissue sarcoma 5. meanoma
Disease:
Population Age: Adults, Elderly		Gender: Male, Female
Trial protocol: BE (Completed) DE (Prematurely Ended) FR (Completed) GB (Prematurely Ended) NL (Completed)
Trial results: View results

EudraCT Number: 2011-004726-10

Sponsor Protocol Number: AMR-01-01-0019

Start Date*: 2012-05-02

Sponsor Name:Amarin Pharma Inc.

Full Title: A Multi-Center, Prospective, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Effect of AMR101 on Cardiovascular Health and Mortality in Hypertriglyceridemic Patie...

Medical condition: Cardiovascular Disease or at High Risk for Cardiovascular Disease

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	20.1	100000004861	10020870	Hypertriglyceridemia	LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: NL (Completed) PL (Completed)

Trial results: View results

EudraCT Number: 2011-006319-69

Sponsor Protocol Number: 1.0

Start Date*: 2012-10-25

Sponsor Name:Pedro Villarejo Campos(Hospital Universitario Ciudad Real)

Full Title: Closed abdomen hyperthermic intraperitoneal chemotherapy with paclitaxel for advanced epithelial ovarian cancer

Medical condition: ovarian cancer (II,III,IV FIGO staging and tumoral recurrence)

Disease:	Version	SOC Term	Classification Code	Term	Level
	14.1	10005329 - Blood and lymphatic system disorders	10028584	Myelosuppression	LLT
	14.1	10007541 - Cardiac disorders	10006093	Bradycardia	PT
	14.1	10017947 - Gastrointestinal disorders	10028813	Nausea	PT
	14.1	10017947 - Gastrointestinal disorders	10012727	Diarrhea	LLT
	14.1	10017947 - Gastrointestinal disorders	10047700	Vomiting	PT
	14.1	10018065 - General disorders and administration site conditions	10028127	Mucositis	LLT
	14.1	10028395 - Musculoskeletal and connective tissue disorders	10003239	Arthralgia	PT
	14.1	10040785 - Skin and subcutaneous tissue disorders	10001760	Alopecia	PT
	14.1	10021881 - Infections and infestations	10046544	Urinary infection	LLT
	14.1	10047065 - Vascular disorders	10021097	Hypotension	PT
	14.1	10028395 - Musculoskeletal and connective tissue disorders	10028411	Myalgia	PT
	14.1	10021881 - Infections and infestations	10038700	Respiratory infection	LLT
	14.1	10029205 - Nervous system disorders	10034610	Peripheral neuropathy NOS	LLT

Population Age: Adults, Elderly

Gender: Female

Trial protocol: ES (Ongoing)

Trial results: (No results available)

EudraCT Number: 2009-016138-29

Sponsor Protocol Number: APL-C-001-09

Start Date*: 2010-05-06

Sponsor Name:Pharma Mar, S.A.

Full Title: “Randomized, Multicenter, Open-label, Phase III Study of Plitidepsin in Combination with Dexamethasone vs. Dexamethasone Alone in Patients with Relapsed/Refractory Multiple Myeloma”.

Medical condition: Relapsed/Refractory Multiple Myeloma

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	12.1		10028228	Multiple myeloma	LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: FR (Completed) GB (Completed) ES (Completed) AT (Completed) NL (Completed) DE (Completed) BE (Completed) CZ (Completed) IT (Completed) GR (Completed) IE (Completed) PT (Completed) PL (Completed)

Trial results: View results

EudraCT Number: 2009-015878-35

Sponsor Protocol Number: BAY63-2521/14308

Start Date*: 2010-03-22

Sponsor Name:Bayer Healthcare AG

Full Title: Randomized, double blind, placebo controlled, parallel group, multi-center study to evaluate the hemodynamic effects of Riociguat (BAY 63-2521) as well as safety and kinetics in patients with pulmo...

Medical condition: Pacientes sintomáticos con una hipertensión pulmonar asociada a una disfunción del ventrículo izquierdo (PH-sLVD)

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	12.0		10037406	Pulmonary hypertension secondary	LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: ES (Completed) DE (Trial now transitioned) NL (Completed) BE (Completed) AT (Completed) FR (Completed) GB (Completed) IT (Trial now transitioned) DK (Completed) CZ (Trial now transitioned)

Trial results: (No results available)

EudraCT Number: 2008-005575-96	Sponsor Protocol Number: LPL100601	Start Date*: 2008-11-26
Sponsor Name:GlaxoSmithKline Research & Development, Ltd
Full Title: A Clinical Outcomes Study of Darapladib versus Placebo in Subjects with Chronic Coronary Heart Disease to Compare the Incidence of Major Adverse Cardiovascular Events (MACE)
Medical condition: chronic Coronary Heart Disease (cCHD)
Disease:
Population Age: Adults, Elderly		Gender: Male, Female
Trial protocol: NL (Completed) ES (Completed) HU (Completed) SE (Completed) DE (Completed) GB (Completed) SK (Completed) FR (Completed) DK (Completed) EE (Completed) BE (Completed) CZ (Completed) PL (Completed) BG (Completed) IT (Completed) GR (Completed)
Trial results: View results

EudraCT Number: 2008-000252-28

Sponsor Protocol Number: SHCVOLT1

Start Date*: 2009-03-13

Sponsor Name:Cambridge University Hospitals NHS Foundation Trust

Full Title: A Multi-Centre Prospective Controlled Trial Comparing Calcineurin Inhibitor Monotherapy With Sirolimus Monotherapy in Hepatitis C Infected Patients with Hepatic Fibrosis Following Liver Transplanta...

Medical condition: Patients who have undergone liver transplantation and are infected with Hepatitis C virus.

Disease:	Version	SOC Term	Classification Code	Term	Level
	9.1		10052779	Transplant rejections	HLT
	9.1		10024970	Respiratory tract infections	HLGT
	9.1		10046577	Urinary tract infections	HLT
	9.1		10001032	Acute pyelonephritis	LLT
	9.1		10040072	Septicaemia	LLT
	9.1		10019972	Herpes viral infections	HLT
	9.1		10028440	Mycobacterial infectious disorders	HLGT
	9.1		10015107	Epstein-Barr viral infections	HLT
	9.1		10011831	Cytomegalovirus infection	LLT
	9.1		10019974	Herpes zoster	LLT
	9.1		10058872	Fungal sepsis	LLT
	9.1		10040808	Skin cancer	PT
	9.1		10051358	Post transplant lymphoproliferative disorder	LLT
	9.1		10043555	Thrombocytopenias	HLT
	9.1		10037561	Purpura thrombocytopenic	LLT
	9.1		10002034	Anaemia	PT
	9.1		10018932	Haemolytic uraemic syndrome	PT
	9.1		10024384	Leukopenia	PT
	9.1		10029355	Neutropenias	HLT
	9.1		10033661	Pancytopenia	PT
	9.1		10013505	Disturbance of liver function tests	LLT
	9.1		10002218	Anaphylaxis	LLT
	9.1		10002425	Angioedemas	HLT
	9.1		10015665	Exfoliative dermatitis	LLT
	9.1		10020764	Hypersensitivity vasculitis	LLT
	9.1		10021015	Hypokalaemia	PT
	9.1		10021058	Hypophosphataemia	PT
	9.1		10020603	Hypercholesterolaemia	PT
	9.1		10020635	Hyperglycaemia	PT
	9.1		10020869	Hypertriglyceridaemia	PT
	9.1		10043071	Tachycardia	PT
	9.1		10034474	Pericardial effusion	PT
	9.1		10048642	Lymphocele	PT
	9.1		10051055	Deep vein thrombosis	PT
	9.1		10037377	Pulmonary embolism	PT
	9.1		10025282	Lymphoedema	PT
	9.1		10035742	Pneumonitis	PT
	9.1		10035598	Pleural effusion	PT
	9.1		10015090	Epistaxis	PT
	9.1		10037394	Pulmonary haemorrhage	PT
	9.1		10000081	Abdominal pain	PT
	9.1		10012735	Diarrhoea	PT
	9.1		10042128	Stomatitis	PT
	9.1		10033645	Pancreatitis	PT
	9.1		10000496	Acne	PT
	9.1		10037844	Rash	PT
	9.1		10003239	Arthralgia	PT
	9.1		10031264	Osteonecrosis	PT
	9.1		10037032	Proteinuria	PT
	9.1		10029164	Nephrotic syndrome	PT
	9.1		10030124	Oedema peripheral	PT
	9.1		10021519	Impaired healing	PT
	9.1		10030095	Oedema	PT
	9.1		10037660	Pyrexia	PT
	9.1		10005630	Blood lactate dehydrogenase increased	PT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: GB (Prematurely Ended)

Trial results: View results

EudraCT Number: 2016-000133-40	Sponsor Protocol Number: 2016-2369	Start Date*: 2016-05-25
Sponsor Name:Gustave Roussy
Full Title: European Proof-of-Concept Therapeutic Stratification Trial of Molecular Anomalies in Relapsed or Refractory Tumors
Medical condition: Relapsed or refractory tumors in children
Disease:
Population Age: Newborns, Infants and toddlers, Children, Adolescents, Under 18, Adults		Gender: Male, Female
Trial protocol: FR (Trial now transitioned) ES (Ongoing) NL (Trial now transitioned) GB (GB - no longer in EU/EEA) IT (Trial now transitioned) DK (Trial now transitioned)
Trial results: (No results available)

Subscribe to this Search
To subscribe to the RSS feed for this search click here

. This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.

Download Options:
Number of Trials to download:

Download Content:

Download Format:


Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial.

Query did not match any studies.

Select Country:	Select Age Range:
Select Trial Status:	Select Trial Phase:
Select Gender:
Select Date Range: to
Select Rare Disease:
IMP with orphan designation in the indication
Orphan Designation Number:
Results Status:
Clear advanced search filters

Austria
Belgium
Bulgaria
Croatia
Cyprus
Czechia
Denmark
Estonia
Finland
France
Germany
Greece
Hungary
Iceland
Ireland
Italy
Latvia
Liechtenstein
Lithuania
Luxembourg
Malta
Netherlands
Norway
Poland
Portugal
Romania
Slovakia
Slovenia
Spain
Sweden
United Kingdom
Outside EU/EEA

Clinical trials for Cardiac Arrhythmia